文献速递神经核医学

癫痫分子影像学更新

Update on Molecular Imaging in Epilepsy.
PubMed 文献 · Semin Nucl Med · 2025-06-13

癫痫是全球常见神经系统疾病,约30%患者为药物难治性癫痫(DRE)。局灶性DRE患者手术前常需分子影像定位致痫区,发作期SPECT是唯一能在体内显示发作起始区的方法,发作间期FDG PET/CT可提供致痫区的大部分信息,SISCOM、SISCOS、PISCOM等先进影像分析技术和新型受体PET示踪剂进一步细化了发作起始区的定位。

要点

  • 约30%癫痫患者为药物难治性癫痫(DRE),局灶性DRE患者可通过手术切除或离断致痫灶获益。
  • 发作期SPECT是唯一能在体内显示发作起始区的影像方法,癫痫仍是灌注SPECT的常见适应证。
  • 发作间期FDG PET/CT可提供致痫区的大部分信息,而SPECT需发作期和发作间期两次检查。

核心结论

  • 在MRI和EEG结果正常、不一致或多发病灶而仅1或2个为致痫灶时,SPECT和PET等分子影像有助于准确勾画致痫区以规划癫痫手术。
  • PET和SPECT还可评估大脑其余部分的功能完整性,并可能为理解这些患者常见的神经认知和行为损害的潜在病理生理提供有价值的信息。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 癫痫以反复非诱发性发作为特征,对日常生活有显著影响。
  • 几乎三分之二癫痫患者对一种或多种抗癫痫药物反应良好,约30%患者为药物难治性癫痫(DRE)。
  • 局灶性DRE患者脑内常有局灶性病理,通过切除或离断致痫样波起源灶与其他大脑皮质部分的联系可大幅获益。
  • 临床检查、MRI和EEG是此类患者术前的一线检查,但许多时候结果正常、不一致或多发病灶,其中仅1或2个为致痫灶。
  • 发作间期FDG PET/CT是单次检查即可提供致痫区大部分信息的方法,而SPECT需行发作期和发作间期两次检查。

关键数值与推荐

  • 约30%癫痫患者为药物难治性癫痫(DRE)。
  • 几乎三分之二癫痫患者对一种或多种抗癫痫药物反应良好。
  • 发作期SPECT是唯一能在体内显示发作起始区的影像方法。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epilepsy is one of the commonest neurological disorders worldwide. It is characterized by recurrent unprovoked seizures and has significant effects on one's daily life. Though almost two thirds of patients with epilepsy respond well with one or more antiepileptic drugs, about 30% patients suffer with drug resistant epilepsy (DRE). Patients with focal variant of DRE, often have a focal pathology in brain and benefit vastly by removing or disconnecting the foci of origin of epileptiform waves from other parts of the cerebral cortex. While clinical examination, MRI and EEG are the first line investigations done in such patients before surgery, many a times they yield normal or discordant or multiple lesions of which only 1 or 2 are epileptogenic. It is in such cases; molecular imaging such as SPECT and PET helps in accurately demarcating the EZ for planning epilepsy surgery. The functional integrity of the rest of the brain can also be assessed by PET and SPECT, which may also offer valuable insights into the potential pathophysiology of the neurocognitive and behavioral impairments commonly seen in these patients. Epilepsy continues to be a common indication for perfusion SPECT as it is the only imaging method that can visualize the ictal onset zone in vivo. Interictal FDG PET/CT is a single investigation that can provide most information about EZ whereas SPECT has to be done twice-ictal and interictal. The evolution of advanced image analysis techniques like SISCOM, SISCOS, PISCOM and newer receptor-based PET tracers has further refined the localization of the seizure onset zone.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Vengadesan K, Phulia A, Kumar R, et al. Update on Molecular Imaging in Epilepsy. Semin Nucl Med. 2025. PMID: 40514317. doi:10.1053/j.semnuclmed.2025.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。